Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Olympus Europe SE & Co. KG
With
Cromsource
This Study aims to provide insight into whether the application of Artificial Intelligence (Olympus Endoscopy Computer-Aided Detection (CADe) system) increases the detection rate of adenomatous polyps in screening and / or surveillance colonoscopy procedures.
Age
45–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Signed informed consent
2. 45-80 years
3. Undergoing colonoscopy for primary CRC screening or postpolypectomy surveillance
You may not be if
1. Lack of informed written consent
2. History of CRC or inflammatory bowel disease or polyposis syndrome / familial adenomatous polyposis coli (FAP)
3. Prior failed colonoscopy
* multiple historic prior failed colonoscopy due to poor bowel preparation OR
* a single prior failed colonoscopy due to reasons other than poor bowel preparation
4. Biopsy/anesthesia/sedation contraindications
5. History of radio- and/or chemotherapy
6. Concurrent participation in another competing clinical study
